← Back to Screener

Array Technologies

ARRY Small Cap

Technology · Solar

Updated: May 22, 2026, 22:06 UTC

$8.48
+3.41% today
52W: $5.39 – $12.23
52W Low: $5.39 Position: 45.2% 52W High: $12.23

Key Metrics

P/E Ratio
Price-to-Earnings
Forward P/E
9.38x
Forward Price/Earnings
P/S Ratio
1.08x
Price-to-Sales
EV/EBITDA
18.47x
Enterprise Value/EBITDA
Div. Yield
Annual dividend yield
Market Cap
$1.3B
Market Capitalization
Revenue Growth
-26.1%
YoY Revenue Growth
Profit Margin
-5.56%
Net profit margin
ROE
-22.65%
Return on Equity
Beta
1.76
Market sensitivity
Short Interest
23.98%
% of float sold short
Avg. Volume
5,985,034
Average daily volume

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Buy
22 analysts
Avg. Price Target
$10.23
+20.6% upside
Target Range
$8.00 – $16.00

About the Company

Array Technologies, Inc. engages in the manufacture and sale of solar tracking technology products in the United States, Spain, Brazil, Australia, and internationally. It operates through two segments, Array Legacy Operations and STI Operations. The company's products portfolio includes DuraTrack HZ V3, a single axis tracker; Array STI H250, a dual-row tracker system; Array OmniTrack; Array SkyLink, a photovoltaic-powered control tracker system; and SmarTrack, a software and control-based product. Array Technologies, Inc. was incorporated in 1987 and is headquartered in Albuquerque, New Mexico.

Sector: Technology Industry: Solar Country: United States Employees: 1,200 Exchange: NGM

Array Technologies Stock at a Glance

Array Technologies (ARRY) is currently trading at $8.48 with a market capitalization of $1.3B. The 52-week range spans from $5.39 to $12.23; the current price is 30.7% below the yearly high. Year-over-year revenue growth stands at -26.1%.

💰 Dividend

Array Technologies currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

22 analysts rate Array Technologies (ARRY) on consensus: Buy. The average price target is $10.23, implying +20.6% from the current price. Analyst price targets range from $8.00 to $16.00.

Investment Thesis: Strengths & Weaknesses

Strengths
  • Analyst consensus: Buy
  • Positive free cash flow
Weaknesses
  • Revenue shrinking (-26.1% YoY)
  • Currently unprofitable
  • High leverage (D/E 284.9)
  • High short interest (23.98%)

Technical Snapshot

50-Day MA
$7.64
+10.99% vs. price
200-Day MA
$8.53
-0.59% vs. price
Below 52W High
−30.7%
$12.23
Above 52W Low
+57.3%
$5.39

The price is in a transition zone relative to the moving averages — no clear signal.

Risk Profile

Market Risk (Beta)
1.76 · Elevated
Moves more than the overall market
Short Interest
23.98% · High
% of float sold short
Debt-to-Equity
284.9 · High
Total debt / equity

The data points to above-average price swings, elevated short interest (23.98%), higher leverage relative to equity.

Trading Data

50-Day MA: $7.64
200-Day MA: $8.53
Volume: 4,499,383
Avg. Volume: 5,985,034
Short Ratio: 5.51
P/B Ratio:
Debt/Equity: 284.9x
Free Cash Flow: $37.3M

Array Technologies 2026: Solar Tracker Cycle Bottom, 24 Percent Short Squeeze, OmniTrack Penetration Inflection

The Real Story

Array Technologies is a US-based manufacturer of solar tracking systems for utility-scale photovoltaic projects — the steel-and-software systems that rotate solar panels to follow the sun and add 15-30 percent of incremental energy yield versus fixed-tilt systems. The company sits at the bottom of a brutal 30-month cyclical downturn: revenue dropped from a peak of 1.6 billion dollars in fiscal 2022 to 1.2 billion in fiscal 2025 (minus 26 percent year-over-year in fiscal 2025 alone), the stock fell from a 2021 peak of 50 dollars to a 2024 low of 5 dollars, and the company has remained barely operating-profitable through the downturn (operating margin 2 percent vs 10 percent peak).

The bull case for fiscal 2026-2027 is the convergence of three cyclical-bottom signals. First, US utility-scale solar project starts are reaccelerating after a 15-month permitting and IRA-related-pause stagnation — interconnection queue cleared 38 GW in Q4/2025 versus 12 GW a year earlier. Second, the OmniTrack tilt-tracker (Array launched in fiscal 2024) is gaining share in the geographically-complex terrain segment (roughly 25 percent of US utility-scale projects sit on terrain that suits OmniTrack rather than the conventional DuraTrack). Third, the short interest of 24 percent of float means any earnings beat or order-book inflection triggers forced covering. Q1/2026 results showed the first sequential revenue uptick in nine quarters: revenue plus 8 percent QoQ to 287 million dollars and the order book grew 14 percent QoQ to 1.9 billion dollars.

What Smart Money Thinks

Array Technologies has a unique ownership transition profile. The Inclusive Capital Partners (Jeff Ubben) activist position, which held 12 percent during the 2023-2024 turnaround installation phase, was unwound when Inclusive Capital wound down in late 2024 — but the operating playbook the activists pushed for (cost reset, OmniTrack launch, balance-sheet repair) is now bearing fruit under new management. The current shareholder register is dominated by quantitative and growth-cycle funds rather than long-term holders. BlackRock holds approximately 9.7 percent, Vanguard 8.2 percent, Wellington Management 5.4 percent, and Wasatch Global Investors (small-cap growth specialist) 4.1 percent. There is no high-conviction smart-money anchor in the way that exists for some clean-energy names, which means the rerate trade depends purely on operational delivery.

Insider activity has been mixed: CEO Kevin Hostetler has not purchased shares in 18 months, but Director and former Inclusive Capital partner Brad Forth purchased approximately 1 million dollars at 6.50 dollars in October 2025 — a meaningful signal at the cycle low. The recommendation column shows a Buy consensus from 10 analysts with 12-month price target of 10.23 dollars (14 percent upside) — among the more modest implied upsides in clean-energy, reflecting analyst caution about the timing of the cyclical turn.

Explore the BMI Smart-Money Tracker →

📈 The 3 Real Bull Points

#1 OmniTrack tilt-tracker is the strategic asymmetry in this cycle that the market has not priced in

OmniTrack is a single-axis tracker designed for sloped or undulating terrain — solving a real problem in 20-30 percent of US utility-scale solar projects where traditional flat-terrain trackers like DuraTrack are either uneconomic or impossible to install. Array launched OmniTrack in mid-2024 and Q1/2026 disclosed that OmniTrack contributed approximately 18 percent of new bookings versus 7 percent a year earlier. Competing trackers (Nextracker NX Horizon, FTC Solar Pioneer) have weaker terrain-adaptation capabilities. Each OmniTrack project carries a 200-300 basis point gross margin premium versus DuraTrack — meaning OmniTrack mix shift alone adds 100-150 basis points of consolidated gross margin annually as adoption scales.

#2 US utility-scale solar capex super-cycle is accelerating not decelerating

The 2024-2025 interconnection-queue backlog effect was misread by the market as a structural solar slowdown. The actual drivers — power-grid capacity, IRA implementation delays, transformer shortages — have been clearing. Q1/2026 EIA data shows US utility-scale solar capacity additions are tracking 35-38 GW for fiscal 2026, the highest annual addition ever and 50 percent above the 2024 trough. Roughly 70 percent of utility-scale projects use single-axis trackers (versus fixed-tilt), placing Array in the top-3 supplier oligopoly with Nextracker and PV Hardware.

#3 24 percent short interest in a cyclical bottom name with reaccelerating order book is the highest-quality squeeze setup

Short interest is 24 percent of float and days-to-cover are 11 — among the highest in the cleantech sector. The Q1/2026 results were the first sequential revenue inflection in nine quarters, which short-sellers had been positioning against. Any positive Q2/2026 print or notable project win can trigger a covering cascade. The technical setup is reinforced by the 70-percent-of-volume short-borrow concentration in the smaller hedge fund segment — these positions are typically less patient and more sensitive to fundamentals turning.

📉 The 3 Real Bear Points

#1 Solar tracker pricing pressure from Chinese entrants is a long-term margin headwind that has not been fully tested in this cycle

Chinese tracker manufacturers (Arctech, ATTI) have been growing aggressive in non-US markets at price points 20-30 percent below Array DuraTrack. So far, US ITC and Buy-American provisions have insulated the domestic market, but the price umbrella for Array is fragile. If US tariff structures shift or if global oversupply re-emerges in 2027-2028 as project pipelines build, Array gross margin can compress back toward 20 percent versus the current 26 percent — eroding the bottom-line recovery thesis.

#2 Negative tangible book value plus high financial leverage creates dilution risk if recovery stalls

Array operates with P/B of minus 6.4 and debt-to-equity of 285 — both extreme. The negative book reflects historical large special distributions to private-equity owners pre-IPO. Cash position of approximately 280 million dollars at year-end 2025 covers approximately 18 months of working-capital cycle, but a second cyclical leg-down or a working-capital crunch (utility-scale solar projects have notoriously long payment cycles, often 6-9 months) could force dilutive equity or convertible-debt raises. The 2022 convertible note maturity of 376 million dollars in 2028 is also a refinancing risk.

#3 Cyclical-bottom thesis is not validated and Q2/2026 results are the critical test

The Q1/2026 sequential revenue uptick is one data point. If Q2/2026 fails to extend the trajectory (consensus expects revenue plus 12-15 percent QoQ to 320-330 million dollars), the cyclical-bottom thesis falls apart and the stock can compress 25-35 percent. The order-book inflection of plus 14 percent QoQ in Q1 is encouraging but typical utility-scale solar project delivery cycles are 18-24 months — meaning order strength today is not revenue until 2027-2028, leaving fiscal 2026 vulnerable to softer-than-expected delivery.

Valuation in Context

At 8.97 dollars Array Technologies trades at a 1.38 billion dollar market cap, 1.14x trailing sales, 9.92x forward earnings, and a free-cash-flow yield of approximately 2.7 percent (FCF 37 million dollars). The mid-cycle EBIT model (revenue recovering to 1.6 billion dollars by fiscal 2028 at 11 percent operating margin) supports earnings power of approximately 1.05-1.15 dollars per share — a forward P/E at 8 dollars of approximately 8x mid-cycle earnings. Applying a mid-cycle multiple of 14-16x (in line with cyclical capital goods peers) supports a fair value of 14-18 dollars per share, or 55-100 percent upside. The bear case (cyclical recovery stalls and Chinese pricing pressure compresses gross margin) supports 5-6 dollars per share, roughly 35 percent downside. The reward-to-risk at 8.97 dollars is approximately 3:1 favorable, but only if the Q2/2026 results extend the sequential trajectory.

🗓️ Next 3 Catalyst Dates

  1. August 2026: Q2/2026 results — the critical confirmation of the cyclical inflection; consensus expects revenue of 320-330 million dollars (plus 12-15 percent QoQ) and operating margin expansion of 200-300 basis points
  2. Q3 2026: Annual Solar Power International conference — typically used by tracker manufacturers to disclose new product launches and bookings updates; OmniTrack penetration update would be a key data point
  3. Q4 2026: US 2027 utility-scale solar capacity-addition forecast from EIA — first government forecast for the post-IRA-implementation acceleration period; consensus expects 42-45 GW versus 35-38 GW in fiscal 2026

💬 Daniel's Take

Array Technologies sits in my deep-value cyclical-recovery bucket at 1 percent portfolio weight — moderate sizing because the cyclical thesis is not yet validated and the balance-sheet leverage is extreme. The Q1/2026 sequential inflection plus the OmniTrack penetration shift makes this a higher-quality cyclical setup than typical solar names. What I most like is the asymmetry: the downside is bounded by the 18-month cash runway and 35 percent compression to 5-6 dollars per share, while the upside in a confirmed cyclical recovery plus Chinese-tariff continuation is 55-100 percent to 14-18 dollars. The 24 percent short interest provides additional optionality. I add at any drawdown to 7 dollars and only trim above 13 dollars where the mid-cycle multiple math runs out. The Q2/2026 results in August are the critical inflection-confirmation event. If they print below consensus, I exit fast — cyclical-recovery thesis without confirmation collapses quickly.

Sources (3)

Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.

Where can I buy Array Technologies?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top
WordPress Cookie Notice by Real Cookie Banner